Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaoming Yin

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Therapeutic Innovation & Regulatory Science|February 17, 2026
Assumption-Agnostic Deep Learning Framework for Holistic Clinical Trial MonitoringShaoming Yin, Zheyang Wu, Jianchang Lin
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|December 12, 2023
Extended Treatment With Recombinant Human Parathyroid Hormone (1-84) in Adult Patients With Chronic HypoparathyroidismMishaela R Rubin, Natalie Cusano, Shaoming Yin, et al.
Bioinformatics (Oxford, England)|April 20, 2012
NanoStringNorm: an extensible R package for the pre-processing of NanoString mRNA and miRNA dataDaryl Waggott, Kenneth Chu, Shaoming Yin, et al.
Orphanet Journal of Rare Diseases|May 7, 2022
Application of Bayesian methods to accelerate rare disease drug development: scopes and hurdlesKelley M Kidwell, Satrajit Roychoudhury, Barbara Wendelberger, et al.
JBMR Plus|May 14, 2024
Open-label extension of a randomized trial investigating safety and efficacy of rhPTH(1-84) in hypoparathyroidismAliya A Khan, Lisa G Abbott, Intekhab Ahmed, et al.
Journal of the Endocrine Society|April 24, 2023
Long-Term Safety and Efficacy of Recombinant Human Parathyroid Hormone (1-84) in Adults With Chronic HypoparathyroidismNelson B Watts, John P Bilezikian, Henry G Bone, et al.
Plos One|April 17, 2015
Developing a prognostic micro-RNA signature for human cervical carcinomaChristine How, Melania Pintilie, Jeff P Bruce, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Therapeutic Innovation & Regulatory Science|February 17, 2026
Assumption-Agnostic Deep Learning Framework for Holistic Clinical Trial MonitoringShaoming Yin, Zheyang Wu, Jianchang Lin
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|December 12, 2023
Extended Treatment With Recombinant Human Parathyroid Hormone (1-84) in Adult Patients With Chronic HypoparathyroidismMishaela R Rubin, Natalie Cusano, Shaoming Yin, et al.
Bioinformatics (Oxford, England)|April 20, 2012
NanoStringNorm: an extensible R package for the pre-processing of NanoString mRNA and miRNA dataDaryl Waggott, Kenneth Chu, Shaoming Yin, et al.
Orphanet Journal of Rare Diseases|May 7, 2022
Application of Bayesian methods to accelerate rare disease drug development: scopes and hurdlesKelley M Kidwell, Satrajit Roychoudhury, Barbara Wendelberger, et al.
JBMR Plus|May 14, 2024
Open-label extension of a randomized trial investigating safety and efficacy of rhPTH(1-84) in hypoparathyroidismAliya A Khan, Lisa G Abbott, Intekhab Ahmed, et al.
Journal of the Endocrine Society|April 24, 2023
Long-Term Safety and Efficacy of Recombinant Human Parathyroid Hormone (1-84) in Adults With Chronic HypoparathyroidismNelson B Watts, John P Bilezikian, Henry G Bone, et al.
Plos One|April 17, 2015
Developing a prognostic micro-RNA signature for human cervical carcinomaChristine How, Melania Pintilie, Jeff P Bruce, et al.
Pageof 1